Cargando…

POS-973 MEASURING SERORESPONSE TO SARS-CoV-2 INFECTION AND VACCINATIONS IN HAEMODIALYSIS PATIENTS

Detalles Bibliográficos
Autores principales:	Warrens, H., Khan, Y., Chung, I., Ma, J., Banerjee, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854821/ http://dx.doi.org/10.1016/j.ekir.2022.01.1013

Ejemplares similares

Seroresponse to SARS-CoV-2 Vaccines Among Maintenance Dialysis Patients
por: Hsu, Caroline M., et al.
Publicado: (2022)

Seroresponse to Third Doses of SARS-CoV-2 Vaccine Among Patients Receiving Maintenance Dialysis
por: Hsu, Caroline M., et al.
Publicado: (2022)

Serial SARS-CoV-2 Antibody Titers in Vaccinated Dialysis Patients: Prevalence of Unrecognized Infection and Duration of Seroresponse
por: Hsu, Caroline M., et al.
Publicado: (2023)

Lack of seroresponse to SARS-CoV-2 booster vaccines given early post-transplant in patients primed pre-transplantation
por: Gleeson, Sarah, et al.
Publicado: (2023)

POS-970 PREVALENCE OF SARS-CoV-2 INFECTION IN HAEMODIALYSIS PATIENTS- A RETROSPECTIVE STUDY
por: VORA, A., et al.
Publicado: (2022)

Quantitation of Human Seroresponsiveness to Merkel Cell Polyomavirus
por: Pastrana, Diana V., et al.
Publicado: (2009)

Influenza Vaccines in Maintenance Hemodialysis Patients: Does Seroresponse Vary With Different Vaccine Formulations?
por: Barbar, Tarek, et al.
Publicado: (2022)

POS-887 GROSS HEMATURIA AFTER SARS-CoV-2 VACCINATION: QUESTIONNAIRE SURVEY IN JAPAN
por: AOKI, R., et al.
Publicado: (2022)

POS-134 NEW ONSET NEPHROTIC SYNDROME FOLLOWING INACTIVATED SARS-CoV-2 VACCINE
por: Lim, Y.S., et al.
Publicado: (2022)

The seroprevalence of SARS-CoV-2 in patients on haemodialysis
por: Mahalingasivam, Viyaasan, et al.
Publicado: (2020)

SARS CoV-2 seropositivity in haemodialysis patients
por: Toapanta, Nestor, et al.
Publicado: (2022)

POS-005 NEUTRALIZING ANTI SARS-CoV-2 ANTIBODY RESPONSE TO COVID - 19 VACCINES: ChAdOx1-nCoV-19 AND BBV152 AMONG HAEMODIALYSIS PATIENTS
por: Selvanathan, D., et al.
Publicado: (2022)

POS-004 NEUTRALIZING ANTI SARS-CoV-2 ANTIBODY RESPONSE TO COVID-19 VACCINES: ChAdOx1-nCoV-19 AND BBV152 AMONG HAEMODIALYSIS PATIENTS
por: Selvanathan, D., et al.
Publicado: (2022)

Antibody response to mRNA SARS-CoV-2 vaccines in haemodialysis patients
por: Paal, Michael, et al.
Publicado: (2021)

Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients—Authors´ Reply
por: Stumpf, Julian, et al.
Publicado: (2021)

Heterogeneous neutralizing antibodies production after SARS-CoV-2 vaccination in haemodialysis patients
por: Lamy, Gaspard, et al.
Publicado: (2021)

Humoral response to SARS-CoV-2 vaccination in haemodialysis patients and a matched cohort
por: Zhao, Tianchen, et al.
Publicado: (2022)

POS-907 COVID-19 AND SARS-CoV-2 VACCINE IN HEMODIALYSIS PATIENTS. EXPERIENCE IN A GUATEMALAN CENTER
por: MAZARIEGOS, C., et al.
Publicado: (2022)

Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis
por: Strengert, Monika, et al.
Publicado: (2021)

Incidence of severe breakthrough SARS-CoV-2 infections in vaccinated kidney transplant and haemodialysis patients
por: Rodríguez-Espinosa, Diana, et al.
Publicado: (2022)

SARS-CoV-2 infection in patients with chronic kidney disease on haemodialysis. Evolution of SARS-CoV-2 CRP()
por: Zúñiga, José, et al.
Publicado: (2021)

Endoplasmic reticulum stress response and bile acid signatures associate with multi-strain seroresponsiveness during elderly influenza vaccination
por: Carre, Christophe, et al.
Publicado: (2021)

Prolonged detection of SARS-CoV-2 RNA in chronic haemodialysis patients
por: Ribitsch, Werner, et al.
Publicado: (2021)

Vaccination against SARS-CoV-2 in Haemodialysis Patients: Spike’s Ab Response and the Influence of BMI and Age
por: Ponce, Pedro, et al.
Publicado: (2022)

Humoral response after SARS-CoV-2 booster vaccination in haemodialysis patients with and without prior infection
por: Füessl, Louise, et al.
Publicado: (2022)

Immunogenicity and safety of inactivated SARS-CoV-2 vaccine in haemodialysis patients: a prospective cohort study
por: Puspitasari, Metalia, et al.
Publicado: (2023)

Distinct immune signatures discriminate between asymptomatic and presymptomatic SARS-CoV-2(pos) subjects
por: Yu, Shanhe, et al.
Publicado: (2021)

128 days of SARS-CoV-2 viral shedding in a haemodialysis patient
por: Heylen, Line, et al.
Publicado: (2021)

Presentation and outcomes of SARS-CoV-2 Omicron variant infection in haemodialysis patients
por: Chimon, Alice, et al.
Publicado: (2022)

POS-961 INCREASED RISK OF EXTRACORPOREAL CIRCUIT CLOTTING IN HAEMODIALYSIS PATIENTS WITH COVID 19
por: Sudusinghe, D.H., et al.
Publicado: (2022)

Measuring cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine (BNT126b2) in patients on maintenance haemodialysis
por: Martin, Paul, et al.
Publicado: (2021)

POS-912 EFFECTIVENESS OF SARS-COV 2 VACCINATION IN KIDNEY TRANSPLANT PATIENTS IN CHILE
por: Pefaur Penna, J., et al.
Publicado: (2022)

POS-879 PREVALENCE OF SARS-CoV-2 INFECTION IN RENAL TRANSPLANT RECIPIENTS- A RETROSPECTIVE STUDY
por: VORA, A., et al.
Publicado: (2022)

SARS-CoV-2 vaccination in haemodialysis patients: Insides from a prospective study comparing mRNA and viral vector vaccines
por: Füessl, Louise, et al.
Publicado: (2022)

实时荧光定量PCR检测人肺腺癌细胞Anip973、Anip973/NVB中hTERT mRNA的表达
Publicado: (2010)

POS-623 NUTRITIONAL STATUS BY SOCIOECONOMIC GROUP DURING COVID-19 PANDEMIC IN HAEMODIALYSIS PATIENTS
por: Hinostroza Yanahuaya, J., et al.
Publicado: (2022)

POS-940 ANTIBODY RESPONSE TO PFIZER BNT162b2 VACCINE IN HEMODIALYSIS PATIENTS: THE PREVIOUS SARS-CoV-2 INFECTION INFLUENCE
por: FREITAS, M., et al.
Publicado: (2022)

POS-861 INCIDENCE AND RISK FACTORS OF ACUTE KIDNEY INJURY WITH SARS-CoV-2 INFECTION IN DISADVANTAGED POPULATION
por: NAVA-VARGAS, M.G., et al.
Publicado: (2022)

Rapid decline of anti-SARS-CoV-2 antibodies in patients on haemodialysis: the COVID-FRIAT study
por: Alcázar-Arroyo, Roberto, et al.
Publicado: (2021)

National survey on current situation of critical value reporting in 973 laboratories in China
por: Fei, Yang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qohb43fl4rr5c49fq28vop64fi